Lataa...
Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
BACKGROUND: Antipsychotic treatment-induced hyperprolactinemia is a highly distressing and disabling side effect for patients. The use of add-on aripiprazole has been identified as a possible treatment strategy in this situation. However, data on prolactin changes with add-on aripiprazole in a real-...
Tallennettuna:
| Julkaisussa: | Indian J Psychol Med |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5795677/ https://ncbi.nlm.nih.gov/pubmed/29403128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/IJPSYM.IJPSYM_147_17 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|